NCT03031769已完成不适用
Symptoms and Physical Activity in COPD Patients in Europe
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,176
- 试验地点
- 1
- 主要终点
- Proportion of patients experiencing symptoms (previous 24 hours) and insufficient physical activity levels (previous month) despite being treated for COPD in real life setting.
研究概览
简要总结
An observational, multinational, cross sectional study to describe 24-hs symptoms, physical activity and their relationship in stable COPD patients in Europe
详细描述
The study is a multi-centre, multi country, observational prospective cross sectional study to determine the prevalence and severity of early morning, day and night-time symptoms and physical activity patterns and to evaluate their correlation between each other and with disease severity, adherence to respiratory medications, direct costs and PROs in patients with stable COPD in Europe.
Approximately 2000 patients will be enrolled in convenient sites in several (9-12) selected countries.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 40 Years 至 130 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female patients aged 40 years or older.
- •Patient has diagnosis of COPD for 1 year or more.
- •Patient has at least one spirometry with COPD criteria, fixed ratio <0.70 post BD, in previous 12 months
- •Patient is a current smoker or an ex-smoker with a smoking history of ≥ 10 pack- years.
- •Stable patients, as stated in medical records or patient reports during visit, defined as: without exacerbation treatment at study visit neither in the previous 2 months, and without changes in maintenance COPD treatment regimen over the preceding 2 months (avoid first consult patient)
- •Patients must be able and willing to read and comprehend written instructions, and comprehend and complete the questionnaires required by the protocol
- •After full explanation, patients must have signed an informed consent document indicating that they understand the purpose of and the procedures required for the study and are willing to participate in the study.
排除标准
- •Patient has diagnosis of sleep apnea syndrome or other chronic respiratory disease different from chronic obstructive diseases. (except for non-idiopathic pulmonary fibrosis and ACOS, only if the main diagnosis is COPD)
- •An acute or chronic condition that, in the investigator's opinion, would limit the patient's ability to complete questionnaires or participate in this study
- •Patient is participating in an ongoing clinical trial that might, in the investigator's opinion, influence the assessment for SPACE study
结局指标
主要结局
Proportion of patients experiencing symptoms (previous 24 hours) and insufficient physical activity levels (previous month) despite being treated for COPD in real life setting.
时间窗: Day 1
次要结局
- • Relationship between 24 hours symptoms (Exact, EMSCI & NiSCI questionnaires) and HRQoL (CAT) on day 1(Day 1)
- • Relationship between 24 hours symptoms (Exact, EMSCI & NiSCI questionnaires) and history of exacerbations (By GOLD definition) in last 12 months(Day 1)
- • Relationship between physical activity levels (YPAS questionnaire) and history of exacerbations (By GOLD definition) in last 12 months(Day 1)
- • Relationship between 24 hours symptoms (Exact, EMSCI & NiSCI questionnaires) and disease classification (By GOLD recommendation) on day 1(Day 1)
- • Relationship between 24 hours symptoms (Exact, EMSCI & NiSCI questionnaires) and level of dyspnea level (mMRC) on day 1(Day 1)
- • Relationship between physical activity levels (YPAS questionnaire) and level of dyspnea level (mMRC) on day 1(Day 1)
- • Relationship between 24 hours symptoms (Exact, EMSCI & NiSCI questionnaires) and physical activity level (YPAS questionnaire) on day 1(Day 1)
- • Relationship between 24 hours symptoms (Exact, EMSCI & NiSCI questionnaires) and adherence to respiratory medication (SRSI for patients and inhalers technique assessed by investigators) on day 1(Day 1)
- • Relationship between physical activity levels (YPAS questionnaire) and adherence to respiratory medication (SRSI for patients and inhalers technique assessed by investigators) on day 1(Day 1)
- • Relationship between physical activity levels (YPAS questionnaire) and disease classification (By GOLD recommendation) on day 1(Day 1)
- • Relationship between physical activity levels (YPAS questionnaire) and HRQoL (CAT) on day 1(Day 1)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Activity, Balance and COPD (ABCOPD)COPDNCT04006015Imperial College London82
已完成
3 期
Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic ObstructiveLung Diseases, ObstructiveNCT00328484National Heart, Lung, and Blood Institute (NHLBI)318
已完成
2 期
Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD)CachexiaNCT03359473GlaxoSmithKline97
终止
不适用
Acute Exacerbation of COPD and Physical Activity - Preliminary StudyChronic Obstructive Pulmonary DiseaseNCT01871246University of Michigan23
Unknown
不适用
Impact of Inspiratory Muscle Training on Daily Physical Activity (INAF)Inspiratory Muscle TrainingNCT03080662Parc de Salut Mar20